[1]
|
Virani, S.S., Alonso, A., Benjamin, E.J., et al. (2020) Heart Disease and Stroke Statistics—2020 Update: A Report from the American Heart Association. Circulation, 141, e139-e596.
|
[2]
|
Choi, S. (2019) The Potential Role of Biomarkers Associated with ASCVD Risk: Risk-Enhancing Biomarkers. Journal of Lipid and Atherosclerosis, 8, 173-182. https://doi.org/10.12997/jla.2019.8.2.173
|
[3]
|
Rosenblit, P.D. (2019) Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition. Current Diabetes Reports, 19, Article No. 61. https://doi.org/10.1007/s11892-019-1178-6
|
[4]
|
Cannon, C.P., Blazing, M.A., Giugliano, R.P., McCagg, A., White, J.A., Theroux, P., et al. (2015) Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. New England Journal of Medicine, 372, 2387-2397. https://doi.org/10.1056/nejmoa1410489
|
[5]
|
Sabatine, M.S., Giugliano, R.P., Keech, A.C., Honarpour, N., Wiviott, S.D., Murphy, S.A., et al. (2017) Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. New England Journal of Medicine, 376, 1713-1722. https://doi.org/10.1056/nejmoa1615664
|
[6]
|
Di Pino, A. and DeFronzo, R.A. (2019) Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents. Endocrine Reviews, 40, 1447-1467. https://doi.org/10.1210/er.2018-00141
|
[7]
|
Beverly, J.K. and Budoff, M.J. (2019) Atherosclerosis: Pathophysiology of Insulin Resistance, Hyperglycemia, Hyperlipidemia, and Inflammation. Journal of Diabetes, 12, 102-104. https://doi.org/10.1111/1753-0407.12970
|
[8]
|
Bornfeldt, K.E. and Tabas, I. (2011) Insulin Resistance, Hyperglycemia, and Atherosclerosis. Cell Metabolism, 14, 575-585. https://doi.org/10.1016/j.cmet.2011.07.015
|
[9]
|
Khan, S.H., Sobia, F., Niazi, N.K., Manzoor, S.M., Fazal, N. and Ahmad, F. (2018) Metabolic Clustering of Risk Factors: Evaluation of Triglyceride-Glucose Index (TyG Index) for Evaluation of Insulin Resistance. Diabetology & Metabolic Syndrome, 10, Article No. 74. https://doi.org/10.1186/s13098-018-0376-8
|
[10]
|
Li, S., Guo, B., Chen, H., Shi, Z., Li, Y., Tian, Q., et al. (2019) The Role of the Triglyceride (Triacylglycerol) Glucose Index in the Development of Cardiovascular Events: A Retrospective Cohort Analysis. Scientific Reports, 9, Article No. 7320. https://doi.org/10.1038/s41598-019-43776-5
|
[11]
|
Sánchez-Íñigo, L., Navarro-González, D., Fernández-Montero, A., Pastrana-Delgado, J. and Martínez, J.A. (2016) The Tyg Index May Predict the Development of Cardiovascular Events. European Journal of Clinical Investigation, 46, 189-197. https://doi.org/10.1111/eci.12583
|
[12]
|
Su, W., Chen, S., Huang, Y., Huang, J., Wu, P., Hsu, W., et al. (2019) Comparison of the Effects of Fasting Glucose, Hemoglobin A1c, and Triglyceride-Glucose Index on Cardiovascular Events in Type 2 Diabetes Mellitus. Nutrients, 11, Article 2838. https://doi.org/10.3390/nu11112838
|
[13]
|
Barzegar, N., Tohidi, M., Hasheminia, M., Azizi, F. and Hadaegh, F. (2020) The Impact of Triglyceride-Glucose Index on Incident Cardiovascular Events during 16 Years of Follow-Up: Tehran Lipid and Glucose Study. Cardiovascular Diabetology, 19, Article No. 155. https://doi.org/10.1186/s12933-020-01121-5
|
[14]
|
Hong, S., Han, K. and Park, C. (2020) The Triglyceride Glucose Index Is a Simple and Low-Cost Marker Associated with Atherosclerotic Cardiovascular Disease: A Population-Based Study. BMC Medicine, 18, Article No. 361. https://doi.org/10.1186/s12916-020-01824-2
|
[15]
|
Park, B., Lee, Y., Lee, H.S. and Jung, D. (2020) The Triglyceride-Glucose Index Predicts Ischemic Heart Disease Risk in Koreans: A Prospective Study Using National Health Insurance Service Data. Cardiovascular Diabetology, 19, Article No. 210. https://doi.org/10.1186/s12933-020-01186-2
|
[16]
|
Tian, X., Zuo, Y., Chen, S., Liu, Q., Tao, B., Wu, S., et al. (2021) Triglyceride-Glucose Index Is Associated with the Risk of Myocardial Infarction: An 11-Year Prospective Study in the Kailuan Cohort. Cardiovascular Diabetology, 20, Article No. 19. https://doi.org/10.1186/s12933-020-01210-5
|
[17]
|
Alizargar, J., Bai, C., Hsieh, N. and Wu, S.V. (2020) Use of the Triglyceride-Glucose Index (TyG) in Cardiovascular Disease Patients. Cardiovascular Diabetology, 19, Article No. 8. https://doi.org/10.1186/s12933-019-0982-2
|
[18]
|
Lee, E.Y., Yang, H.K., Lee, J., Kang, B., Yang, Y., Lee, S., et al. (2016) Triglyceride Glucose Index, a Marker of Insulin Resistance, Is Associated with Coronary Artery Stenosis in Asymptomatic Subjects with Type 2 Diabetes. Lipids in Health and Disease, 15, Article No. 155. https://doi.org/10.1186/s12944-016-0324-2
|
[19]
|
Shi, W., Xing, L., Jing, L., Tian, Y., Yan, H., Sun, Q., et al. (2020) Value of Triglyceride-Glucose Index for the Estimation of Ischemic Stroke Risk: Insights from a General Population. Nutrition, Metabolism and Cardiovascular Diseases, 30, 245-253. https://doi.org/10.1016/j.numecd.2019.09.015
|
[20]
|
Wheatcroft, S.B., Williams, I.L., Shah, A.M. and Kearney, M.T. (2003) Pathophysiological Implications of Insulin Resistance on Vascular Endothelial Function. Diabetic Medicine, 20, 255-268. https://doi.org/10.1046/j.1464-5491.2003.00869.x
|
[21]
|
Guerrero-Romero, F., Simental-Mendía, L.E., González-Ortiz, M., Martínez-Abundis, E., Ramos-Zavala, M.G., Hernández-González, S.O., et al. (2010) The Product of Triglycerides and Glucose, a Simple Measure of Insulin Sensitivity. Comparison with the Euglycemic-Hyperinsulinemic Clamp. The Journal of Clinical Endocrinology & Metabolism, 95, 3347-3351. https://doi.org/10.1210/jc.2010-0288
|